CINDA INTL HLDG(00111): Extend the public listing for the sale of two subsidiary companies.
Sinopharm International Holdings (00111) announced that it will publicly list Sinopharm International Shanghai and Sinopharm Leading for sale.
CINDA INTL HLDG (00111) announced the public listing for the sale of 100% equity of Cinda International Shanghai and Cinda Leading, as disclosed in a previous announcement. The listing for sale will be open for 20 business days starting from August 22, 2024 (excluding Chinese public holidays). The tender period will end on September 19, 2024, and the company did not receive any bids from public listing bidders. Therefore, the Board of Directors has decided to extend the public listing under the same conditions until a successful bidder is found, but the extension will not exceed 1 year from the date of the public listing announcement.
Related Articles

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


